{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:06:23Z","timestamp":1792613183883,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Biallelic mutations in <jats:italic>GBA1<\/jats:italic>, which encodes the lysosomal enzyme glucocerebrosidase, cause the lysosomal storage disorder Gaucher disease (GD). In addition, mutations in <jats:italic>GBA1<\/jats:italic> are the most common genetic risk factor for future development of Parkinson's disease (PD). However, most mutation carriers will never develop parkinsonism. Olfactory dysfunction is often a prodromal symptom in patients with PD, appearing many years prior to motor dysfunction. The purpose of this study was to assess olfactory function longitudinally in individuals with and without parkinsonism who carry at least one <jats:italic>GBA1<\/jats:italic> mutation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred seventeen individuals who participated in a natural history study of GD at the National Institutes of Health were evaluated using the University of Pennsylvania Smell Identification Test (UPSIT) during a 16-year period. Seventy patients with GD (13 with PD) and 47 <jats:italic>GBA1<\/jats:italic> carriers (9 with PD) were included. Fifty-six of the total (47.9%) were seen over multiple visits, and had UPSIT screening performed two to six times, with time intervals between testing ranging from 2 to 6 years. Comparative and control data were obtained from the Parkinson's Progression Markers Initiative (PPMI) database (519 individuals, including 340 with idiopathic PD and 179 healthy controls). Statistical analysis was performed using R.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Severe hyposmia and anosmia was evident in both <jats:italic>GBA1<\/jats:italic> heterozygotes and homozygotes with PD. 84% without parkinsonism had UPSIT scores &amp;gt;30, and those who underwent repeated testing maintained olfactory function over time. No statistically significant difference in UPSIT scores was found between mutation carriers with and without a family history of parkinsonism. A small group of individuals without PD scored in the moderate-severe microsmia range. No significant differences in olfaction were found among our <jats:italic>GBA1<\/jats:italic>-PD cohort and idiopathic PD cohort obtained from PPMI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.1039214","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T05:18:25Z","timestamp":1666070305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Grisel J.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emory","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail L.","family":"Lecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000381619","article-title":"Olfaction and aging: a mini-review","volume":"61","author":"Attems","year":"2015","journal-title":"Gerontology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11882-018-0796-4","article-title":"Olfactory dysfunction in neurodegenerative diseases","volume":"18","author":"Marin","year":"2018","journal-title":"Curr Allergy Asthma Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0021-9681(75)90058-2","article-title":"Olfactory function in patients with Parkinson's disease","volume":"28","author":"Ansari","year":"1975","journal-title":"J Chronic Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat Rev Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","article-title":"University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic","volume":"94","author":"Doty","year":"1984","journal-title":"Laryngoscope."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/mds.22534","article-title":"Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study","volume":"24","author":"Ponsen","year":"2009","journal-title":"Mov Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12264-017-0159-5","article-title":"Premotor diagnosis of Parkinson's disease","volume":"33","author":"Reichmann","year":"2017","journal-title":"Neurosci Bull."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.parkreldis.2014.08.006","article-title":"Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease","volume":"20","author":"Driver-Dunckley","year":"2014","journal-title":"Parkinsonism Relat Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-019-02115-8","article-title":"Neuroprotection in Parkinson's disease: facts and hopes","volume":"127","author":"Salamon","year":"2020","journal-title":"J Neural Transm (Vienna)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","article-title":"Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","article-title":"The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations","volume":"65","author":"Goker-Alpan","year":"2008","journal-title":"Arch Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/jnnp-2019-320394","article-title":"Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study","volume":"90","author":"Avenali","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/mds.27775","article-title":"Evolution and clustering of prodromal parkinsonian features in GBA1 carriers","volume":"34","author":"Mullin","year":"2019","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AIDHUMU7>3.0.CO;2-S","article-title":"Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease","volume":"15","author":"Stone","year":"2000","journal-title":"Hum Mutat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform."},{"key":"B19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/life12050648","article-title":"The R language: an engine for bioinformatics and data science","volume":"12","author":"Giorgi","year":"2022","journal-title":"Life."},{"key":"B20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/chemse\/24.6.697","article-title":"What a tangled web we weave: discriminating between malingering and anosmia","volume":"24","author":"Kurtz","year":"1999","journal-title":"Chem Senses."},{"key":"B21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/alr.22587","article-title":"Smell dysfunction: a biomarker for COVID-19","volume":"10","author":"Moein","year":"2020","journal-title":"Int Forum Allergy Rhinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/gim.2012.107","article-title":"Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling","volume":"15","author":"Rana","year":"2013","journal-title":"Genet Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1039214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T05:18:29Z","timestamp":1666070309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1039214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":23,"alternative-id":["10.3389\/fneur.2022.1039214"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1039214","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"article-number":"1039214"}}